Your browser doesn't support javascript.
loading
Distinct lineages of Ebola virus in Guinea during the 2014 West African epidemic.
Simon-Loriere, Etienne; Faye, Ousmane; Faye, Oumar; Koivogui, Lamine; Magassouba, Nfaly; Keita, Sakoba; Thiberge, Jean-Michel; Diancourt, Laure; Bouchier, Christiane; Vandenbogaert, Matthias; Caro, Valérie; Fall, Gamou; Buchmann, Jan P; Matranga, Christan B; Sabeti, Pardis C; Manuguerra, Jean-Claude; Holmes, Edward C; Sall, Amadou A.
Afiliação
  • Simon-Loriere E; 1] Institut Pasteur, Functional Genetics of Infectious Diseases Unit, 75724 Paris Cedex 15, France [2] CNRS URA3012, Paris 75015, France.
  • Faye O; Institut Pasteur de Dakar, Arbovirus and Viral Hemorrhagic Fever Unit, BP 220, Dakar, Senegal.
  • Faye O; Institut Pasteur de Dakar, Arbovirus and Viral Hemorrhagic Fever Unit, BP 220, Dakar, Senegal.
  • Koivogui L; Institut National de Santé Publique de Guinée, Conakry, Guinea.
  • Magassouba N; Projet de fièvres hémorragiques de Guinée, Université Gamal Abdel Nasser, BP 1147, Conakry, Guinea.
  • Keita S; Ministry of Health, BP 585 Conakry, Guinea.
  • Thiberge JM; Institut Pasteur, Unité Environnement et Risques Infectieux, Cellule d'Intervention Biologique d'Urgence, 75724 Paris Cedex 15, France.
  • Diancourt L; Institut Pasteur, Unité Environnement et Risques Infectieux, Cellule d'Intervention Biologique d'Urgence, 75724 Paris Cedex 15, France.
  • Bouchier C; Institut Pasteur, Genomic platform, 75724 Paris Cedex 15, France.
  • Vandenbogaert M; Institut Pasteur, Unité Environnement et Risques Infectieux, Cellule d'Intervention Biologique d'Urgence, 75724 Paris Cedex 15, France.
  • Caro V; Institut Pasteur, Unité Environnement et Risques Infectieux, Cellule d'Intervention Biologique d'Urgence, 75724 Paris Cedex 15, France.
  • Fall G; Institut Pasteur de Dakar, Arbovirus and Viral Hemorrhagic Fever Unit, BP 220, Dakar, Senegal.
  • Buchmann JP; Marie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, School of Biological Sciences and Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Matranga CB; Broad Institute, 75 Ames Street, Cambridge, Massachusetts 02142, USA.
  • Sabeti PC; 1] Broad Institute, 75 Ames Street, Cambridge, Massachusetts 02142, USA [2] FAS Center for Systems Biology, Department of Organismic and Evolutionary Biology, Harvard University, 52 Oxford Street, Cambridge, Massachusetts 02138, USA.
  • Manuguerra JC; Institut Pasteur, Unité Environnement et Risques Infectieux, Cellule d'Intervention Biologique d'Urgence, 75724 Paris Cedex 15, France.
  • Holmes EC; Marie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, School of Biological Sciences and Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Sall AA; Institut Pasteur de Dakar, Arbovirus and Viral Hemorrhagic Fever Unit, BP 220, Dakar, Senegal.
Nature ; 524(7563): 102-4, 2015 Aug 06.
Article em En | MEDLINE | ID: mdl-26106863
ABSTRACT
An epidemic of Ebola virus disease of unprecedented scale has been ongoing for more than a year in West Africa. As of 29 April 2015, there have been 26,277 reported total cases (of which 14,895 have been laboratory confirmed) resulting in 10,899 deaths. The source of the outbreak was traced to the prefecture of Guéckédou in the forested region of southeastern Guinea. The virus later spread to the capital, Conakry, and to the neighbouring countries of Sierra Leone, Liberia, Nigeria, Senegal and Mali. In March 2014, when the first cases were detected in Conakry, the Institut Pasteur of Dakar, Senegal, deployed a mobile laboratory in Donka hospital to provide diagnostic services to the greater Conakry urban area and other regions of Guinea. Through this process we sampled 85 Ebola viruses (EBOV) from patients infected from July to November 2014, and report their full genome sequences here. Phylogenetic analysis reveals the sustained transmission of three distinct viral lineages co-circulating in Guinea, including the urban setting of Conakry and its surroundings. One lineage is unique to Guinea and closely related to the earliest sampled viruses of the epidemic. A second lineage contains viruses probably reintroduced from neighbouring Sierra Leone on multiple occasions, while a third lineage later spread from Guinea to Mali. Each lineage is defined by multiple mutations, including non-synonymous changes in the virion protein 35 (VP35), glycoprotein (GP) and RNA-dependent RNA polymerase (L) proteins. The viral GP is characterized by a glycosylation site modification and mutations in the mucin-like domain that could modify the outer shape of the virion. These data illustrate the ongoing ability of EBOV to develop lineage-specific and potentially phenotypically important variation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Filogenia / Variação Genética / Doença pelo Vírus Ebola / Ebolavirus / Mutação Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Filogenia / Variação Genética / Doença pelo Vírus Ebola / Ebolavirus / Mutação Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article